𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Calcium channel blockers and β-blockers in relation to Parkinson's disease

✍ Scribed by Thanh G.N. Ton; Susan R. Heckbert; W.T. Longstreth Jr.; Mary Anne Rossing; Walter A. Kukull; Gary M. Franklin; Phillip D. Swanson; Terri Smith-Weller; Harvey Checkoway

Book ID
116820270
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
118 KB
Volume
13
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Calcium channel blocker use and risk of
Calcium channel blocker use and risk of Parkinson's disease
✍ Kelly Claire Simon; Xiang Gao; Honglei Chen; Michael A. Schwarzschild; Alberto A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 1 views

## Abstract We investigated whether the use of calcium channel blockers (CCBs) was associated with a reduced risk of Parkinson's disease (PD) in two large prospective cohorts: the Nurses' Health Study (NHS) and Health Professionals' Follow‐Up Study (HPFS). Cox proportional hazards models were used

Calcium channel blockers in the treatmen
Calcium channel blockers in the treatment of disease
✍ Keith S. Elmslie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Abstract Over the last 20 years the combination of patch clamp and molecular biology techniques have resulted in an explosion in our knowledge of the different calcium channel types and their roles in physiology. A crucial component to this advance has been the discovery of specific blockers for